10 20 30 40 50 60 70 80 2FFR - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 20-DEC-05 2FFR
TITLE CRYSTALLOGRAPHIC STUDIES ON N-AZIDO-BETA-D-GLUCOPYRANOSYLAMINE, AN TITLE 2 INHIBITOR OF GLYCOGEN PHOSPHORYLASE: COMPARISON WITH N-ACETYL-BETA-D- TITLE 3 GLUCOPYRANOSYLAMINE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN PHOSPHORYLASE, MUSCLE FORM; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MYOPHOSPHORYLASE; COMPND 5 EC: 2.4.1.1
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 TISSUE: MUSCLE
KEYWDS GLYCOGENOLYSIS, INHIBITION, TYPE 2 DIABETES, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR E.I.PETSALAKIS,E.D.CHRYSINA,C.TIRAIDIS,T.HADJILOI,D.D.LEONIDAS, AUTHOR 2 N.G.OIKONOMAKOS,U.AICH,B.VARGHESE,D.LOGANATHAN
REVDAT 4 13-JUL-11 2FFR 1 VERSN REVDAT 3 24-FEB-09 2FFR 1 VERSN REVDAT 2 04-JUL-06 2FFR 1 JRNL REVDAT 1 20-JUN-06 2FFR 0
JRNL AUTH E.I.PETSALAKIS,E.D.CHRYSINA,C.TIRAIDIS,T.HADJILOI, JRNL AUTH 2 D.D.LEONIDAS,N.G.OIKONOMAKOS,U.AICH,B.VARGHESE,D.LOGANATHAN JRNL TITL CRYSTALLOGRAPHIC STUDIES ON JRNL TITL 2 N-AZIDOACETYL-BETA-D-GLUCOPYRANOSYLAMINE, AN INHIBITOR OF JRNL TITL 3 GLYCOGEN PHOSPHORYLASE: COMPARISON WITH JRNL TITL 4 N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE. JRNL REF BIOORG.MED.CHEM. V. 14 5316 2006 JRNL REFN ISSN 0968-0896 JRNL PMID 16616506 JRNL DOI 10.1016/J.BMC.2006.03.044
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.ANAGNOSTOU,M.N.KOSMOPOULOU,E.D.CHRYSINA,D.D.LEONIDAS, REMARK 1 AUTH 2 C.TIRAIDIS,T.HADJILOI,S.E.ZOGRAPHOS,Z.GYORGYDEAK,L.SOMSAK, REMARK 1 AUTH 3 T.DOCSA,P.GERGELY,F.N.KOLISIS,N.G.OIKONOMAKOS REMARK 1 TITL CRYSTALLOGRAPHIC STUDIES ON TWO BIOISOSTERIC ANALOGUES, REMARK 1 TITL 2 N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE AND REMARK 1 TITL 3 N-TRIFLUORACETYL-BETA-D-GLUCOPYRANOSYLAMINE, POTENT REMARK 1 TITL 4 INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE REMARK 1 REF BIOORG.MED.CHEM. V. 14 181 2006 REMARK 1 REFN ISSN 0968-0896 REMARK 1 PMID 16213146 REMARK 1 DOI 10.1016/J.BMC.2005.08.010
REMARK 2 REMARK 2 RESOLUTION. 2.03 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.48 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 3632333.310 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 62790 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3172 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.03 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 9726 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE : 0.2690 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 517 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6590 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 358 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.31000 REMARK 3 B22 (A**2) : 3.31000 REMARK 3 B33 (A**2) : -6.61000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.85 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.260 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.000 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.140 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.300 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 46.10 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : PLP.PARAM REMARK 3 PARAMETER FILE 4 : DL6.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : PLP.TOP REMARK 3 TOPOLOGY FILE 4 : DL6.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED
REMARK 4 REMARK 4 2FFR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-06. REMARK 100 THE RCSB ID CODE IS RCSB035825.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62829 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.030 REMARK 200 RESOLUTION RANGE LOW (A) : 29.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.56300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1WW2 REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 MM BES BUFFER, 0.1 MM EDTA, 0.02% REMARK 280 NAN3, 3 MM DTT, PH 6.7, SMALL TUBES, TEMPERATURE 289K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.08150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 64.31300 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 64.31300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.12225 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 64.31300 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 64.31300 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 29.04075 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 64.31300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.31300 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.12225 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 64.31300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.31300 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.04075 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.08150 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: DIMERIC GLYCOGEN PHOSPHORYLASE IS THE PHYSIOLOGIACALLY REMARK 300 ACTIVE SPECIES
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 6650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 56390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 116.16300
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 255 REMARK 465 ASP A 256 REMARK 465 PHE A 257 REMARK 465 ASN A 258 REMARK 465 VAL A 259 REMARK 465 GLY A 260 REMARK 465 LYS A 315 REMARK 465 PHE A 316 REMARK 465 GLY A 317 REMARK 465 CYS A 318 REMARK 465 ARG A 319 REMARK 465 ASP A 320 REMARK 465 PRO A 321 REMARK 465 ARG A 322 REMARK 465 VAL A 323
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG A 205 OD2 ASP A 217 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1281 O HOH A 1281 7556 1.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 15 -8.57 -56.22 REMARK 500 ALA A 19 65.32 -112.18 REMARK 500 ARG A 93 153.99 -44.88 REMARK 500 LEU A 131 40.11 -87.11 REMARK 500 TYR A 203 -135.62 61.65 REMARK 500 ARG A 234 52.75 32.02 REMARK 500 ASN A 253 10.16 55.49 REMARK 500 PRO A 281 28.76 -78.60 REMARK 500 SER A 313 44.55 -97.89 REMARK 500 PHE A 326 2.13 -62.33 REMARK 500 ASP A 339 -159.96 78.01 REMARK 500 THR A 466 -91.58 -121.48 REMARK 500 LEU A 492 -71.70 -146.79 REMARK 500 ASP A 514 68.46 -159.00 REMARK 500 LYS A 554 77.32 49.68 REMARK 500 LYS A 568 169.09 174.64 REMARK 500 SER A 674 -62.20 -144.59 REMARK 500 SER A 751 67.24 -151.40 REMARK 500 HIS A 768 59.88 -145.66 REMARK 500 ASN A 793 79.57 -119.42 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1319 DISTANCE = 6.12 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP A 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DL6 A 998
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WW2 RELATED DB: PDB REMARK 900 THE SAME COMPLEX WITH N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE
DBREF 2FFR A 12 836 UNP P00489 PYGM_RABIT 12 836
SEQADV 2FFR ARG A 322 UNP P00489 VAL 322 CONFLICT SEQADV 2FFR VAL A 323 UNP P00489 ARG 323 CONFLICT
SEQRES 1 A 825 GLN ILE SER VAL ARG GLY LEU ALA GLY VAL GLU ASN VAL SEQRES 2 A 825 THR GLU LEU LYS LYS ASN PHE ASN ARG HIS LEU HIS PHE SEQRES 3 A 825 THR LEU VAL LYS ASP ARG ASN VAL ALA THR PRO ARG ASP SEQRES 4 A 825 TYR TYR PHE ALA LEU ALA HIS THR VAL ARG ASP HIS LEU SEQRES 5 A 825 VAL GLY ARG TRP ILE ARG THR GLN GLN HIS TYR TYR GLU SEQRES 6 A 825 LYS ASP PRO LYS ARG ILE TYR TYR LEU SER LEU GLU PHE SEQRES 7 A 825 TYR MET GLY ARG THR LEU GLN ASN THR MET VAL ASN LEU SEQRES 8 A 825 ALA LEU GLU ASN ALA CYS ASP GLU ALA THR TYR GLN LEU SEQRES 9 A 825 GLY LEU ASP MET GLU GLU LEU GLU GLU ILE GLU GLU ASP SEQRES 10 A 825 ALA GLY LEU GLY ASN GLY GLY LEU GLY ARG LEU ALA ALA SEQRES 11 A 825 CYS PHE LEU ASP SER MET ALA THR LEU GLY LEU ALA ALA SEQRES 12 A 825 TYR GLY TYR GLY ILE ARG TYR GLU PHE GLY ILE PHE ASN SEQRES 13 A 825 GLN LYS ILE CYS GLY GLY TRP GLN MET GLU GLU ALA ASP SEQRES 14 A 825 ASP TRP LEU ARG TYR GLY ASN PRO TRP GLU LYS ALA ARG SEQRES 15 A 825 PRO GLU PHE THR LEU PRO VAL HIS PHE TYR GLY ARG VAL SEQRES 16 A 825 GLU HIS THR SER GLN GLY ALA LYS TRP VAL ASP THR GLN SEQRES 17 A 825 VAL VAL LEU ALA MET PRO TYR ASP THR PRO VAL PRO GLY SEQRES 18 A 825 TYR ARG ASN ASN VAL VAL ASN THR MET ARG LEU TRP SER SEQRES 19 A 825 ALA LYS ALA PRO ASN ASP PHE ASN LEU LYS ASP PHE ASN SEQRES 20 A 825 VAL GLY GLY TYR ILE GLN ALA VAL LEU ASP ARG ASN LEU SEQRES 21 A 825 ALA GLU ASN ILE SER ARG VAL LEU TYR PRO ASN ASP ASN SEQRES 22 A 825 PHE PHE GLU GLY LYS GLU LEU ARG LEU LYS GLN GLU TYR SEQRES 23 A 825 PHE VAL VAL ALA ALA THR LEU GLN ASP ILE ILE ARG ARG SEQRES 24 A 825 PHE LYS SER SER LYS PHE GLY CYS ARG ASP PRO ARG VAL SEQRES 25 A 825 THR ASN PHE ASP ALA PHE PRO ASP LYS VAL ALA ILE GLN SEQRES 26 A 825 LEU ASN ASP THR HIS PRO SER LEU ALA ILE PRO GLU LEU SEQRES 27 A 825 MET ARG VAL LEU VAL ASP LEU GLU ARG LEU ASP TRP ASP SEQRES 28 A 825 LYS ALA TRP GLU VAL THR VAL LYS THR CYS ALA TYR THR SEQRES 29 A 825 ASN HIS THR VAL LEU PRO GLU ALA LEU GLU ARG TRP PRO SEQRES 30 A 825 VAL HIS LEU LEU GLU THR LEU LEU PRO ARG HIS LEU GLN SEQRES 31 A 825 ILE ILE TYR GLU ILE ASN GLN ARG PHE LEU ASN ARG VAL SEQRES 32 A 825 ALA ALA ALA PHE PRO GLY ASP VAL ASP ARG LEU ARG ARG SEQRES 33 A 825 MET SER LEU VAL GLU GLU GLY ALA VAL LYS ARG ILE ASN SEQRES 34 A 825 MET ALA HIS LEU CYS ILE ALA GLY SER HIS ALA VAL ASN SEQRES 35 A 825 GLY VAL ALA ARG ILE HIS SER GLU ILE LEU LYS LYS THR SEQRES 36 A 825 ILE PHE LYS ASP PHE TYR GLU LEU GLU PRO HIS LYS PHE SEQRES 37 A 825 GLN ASN LYS THR ASN GLY ILE THR PRO ARG ARG TRP LEU SEQRES 38 A 825 VAL LEU CYS ASN PRO GLY LEU ALA GLU ILE ILE ALA GLU SEQRES 39 A 825 ARG ILE GLY GLU GLU TYR ILE SER ASP LEU ASP GLN LEU SEQRES 40 A 825 ARG LYS LEU LEU SER TYR VAL ASP ASP GLU ALA PHE ILE SEQRES 41 A 825 ARG ASP VAL ALA LYS VAL LYS GLN GLU ASN LYS LEU LYS SEQRES 42 A 825 PHE ALA ALA TYR LEU GLU ARG GLU TYR LYS VAL HIS ILE SEQRES 43 A 825 ASN PRO ASN SER LEU PHE ASP VAL GLN VAL LYS ARG ILE SEQRES 44 A 825 HIS GLU TYR LYS ARG GLN LEU LEU ASN CYS LEU HIS VAL SEQRES 45 A 825 ILE THR LEU TYR ASN ARG ILE LYS LYS GLU PRO ASN LYS SEQRES 46 A 825 PHE VAL VAL PRO ARG THR VAL MET ILE GLY GLY LYS ALA SEQRES 47 A 825 ALA PRO GLY TYR HIS MET ALA LYS MET ILE ILE LYS LEU SEQRES 48 A 825 ILE THR ALA ILE GLY ASP VAL VAL ASN HIS ASP PRO VAL SEQRES 49 A 825 VAL GLY ASP ARG LEU ARG VAL ILE PHE LEU GLU ASN TYR SEQRES 50 A 825 ARG VAL SER LEU ALA GLU LYS VAL ILE PRO ALA ALA ASP SEQRES 51 A 825 LEU SER GLU GLN ILE SER THR ALA GLY THR GLU ALA SER SEQRES 52 A 825 GLY THR GLY ASN MET LYS PHE MET LEU ASN GLY ALA LEU SEQRES 53 A 825 THR ILE GLY THR MET ASP GLY ALA ASN VAL GLU MET ALA SEQRES 54 A 825 GLU GLU ALA GLY GLU GLU ASN PHE PHE ILE PHE GLY MET SEQRES 55 A 825 ARG VAL GLU ASP VAL ASP ARG LEU ASP GLN ARG GLY TYR SEQRES 56 A 825 ASN ALA GLN GLU TYR TYR ASP ARG ILE PRO GLU LEU ARG SEQRES 57 A 825 GLN ILE ILE GLU GLN LEU SER SER GLY PHE PHE SER PRO SEQRES 58 A 825 LYS GLN PRO ASP LEU PHE LYS ASP ILE VAL ASN MET LEU SEQRES 59 A 825 MET HIS HIS ASP ARG PHE LYS VAL PHE ALA ASP TYR GLU SEQRES 60 A 825 GLU TYR VAL LYS CYS GLN GLU ARG VAL SER ALA LEU TYR SEQRES 61 A 825 LYS ASN PRO ARG GLU TRP THR ARG MET VAL ILE ARG ASN SEQRES 62 A 825 ILE ALA THR SER GLY LYS PHE SER SER ASP ARG THR ILE SEQRES 63 A 825 ALA GLN TYR ALA ARG GLU ILE TRP GLY VAL GLU PRO SER SEQRES 64 A 825 ARG GLN ARG LEU PRO ALA
HET PLP A 999 15 HET DL6 A 998 18
HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM DL6 2-AZIDO-N-((2R,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6- HETNAM 2 DL6 (HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YL)ACETAMIDE
HETSYN PLP VITAMIN B6 PHOSPHATE HETSYN DL6 N-AZIDOACETYL-BETA-D-GLUCOPYRANOSYLAMINE
FORMUL 2 PLP C8 H10 N O6 P FORMUL 3 DL6 C8 H14 N4 O6 FORMUL 4 HOH *358(H2 O)
HELIX 1 1 ILE A 13 GLY A 17 5 5 HELIX 2 2 GLY A 20 THR A 38 1 19 HELIX 3 3 THR A 47 ASP A 78 1 32 HELIX 4 4 THR A 94 LEU A 102 1 9 HELIX 5 5 LEU A 104 LEU A 115 1 12 HELIX 6 6 ASP A 118 GLU A 124 1 7 HELIX 7 7 GLY A 134 LEU A 150 1 17 HELIX 8 8 PRO A 194 THR A 197 5 4 HELIX 9 9 GLY A 261 ASP A 268 1 8 HELIX 10 10 ASP A 268 ASN A 274 1 7 HELIX 11 11 ILE A 275 ARG A 277 5 3 HELIX 12 12 LYS A 289 SER A 313 1 25 HELIX 13 13 ASN A 325 ASP A 327 5 3 HELIX 14 14 ALA A 328 LYS A 332 1 5 HELIX 15 15 LEU A 344 LEU A 356 1 13 HELIX 16 16 ASP A 360 THR A 371 1 12 HELIX 17 17 LEU A 380 LEU A 384 5 5 HELIX 18 18 VAL A 389 LEU A 396 1 8 HELIX 19 19 LEU A 396 PHE A 418 1 23 HELIX 20 20 ASP A 421 SER A 429 1 9 HELIX 21 21 MET A 441 GLY A 448 1 8 HELIX 22 22 ALA A 456 THR A 466 1 11 HELIX 23 23 PHE A 468 GLU A 475 1 8 HELIX 24 24 ASN A 496 GLY A 508 1 13 HELIX 25 25 GLU A 509 VAL A 525 5 17 HELIX 26 26 ASP A 527 GLU A 552 1 26 HELIX 27 27 HIS A 571 LYS A 574 5 4 HELIX 28 28 ARG A 575 GLU A 593 1 19 HELIX 29 29 TYR A 613 ASN A 631 1 19 HELIX 30 30 ARG A 649 ILE A 657 1 9 HELIX 31 31 PRO A 658 ALA A 660 5 3 HELIX 32 32 THR A 676 ASN A 684 1 9 HELIX 33 33 ALA A 695 GLY A 704 1 10 HELIX 34 34 GLU A 705 PHE A 708 5 4 HELIX 35 35 ARG A 714 GLY A 725 1 12 HELIX 36 36 ASN A 727 ILE A 735 1 9 HELIX 37 37 ILE A 735 GLY A 748 1 14 HELIX 38 38 PHE A 758 HIS A 768 1 11 HELIX 39 39 VAL A 773 ALA A 775 5 3 HELIX 40 40 ASP A 776 LYS A 792 1 17 HELIX 41 41 ASN A 793 THR A 807 1 15 HELIX 42 42 SER A 808 PHE A 811 5 4 HELIX 43 43 SER A 812 ILE A 824 1 13
SHEET 1 A 3 LYS A 191 ALA A 192 0 SHEET 2 A 3 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 A 3 LEU A 198 PHE A 202 -1 N LEU A 198 O ALA A 223 SHEET 1 B 9 LYS A 191 ALA A 192 0 SHEET 2 B 9 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 B 9 VAL A 238 LYS A 247 -1 O SER A 245 N MET A 224 SHEET 4 B 9 ALA A 154 ILE A 159 1 N GLY A 156 O ARG A 242 SHEET 5 B 9 ARG A 81 LEU A 85 1 N ILE A 82 O TYR A 155 SHEET 6 B 9 VAL A 333 ASN A 338 1 O ALA A 334 N TYR A 83 SHEET 7 B 9 CYS A 372 THR A 375 1 O ALA A 373 N LEU A 337 SHEET 8 B 9 ALA A 451 GLY A 454 1 O ALA A 451 N TYR A 374 SHEET 9 B 9 PHE A 479 ASN A 481 1 O GLN A 480 N VAL A 452 SHEET 1 C 2 ASN A 167 CYS A 171 0 SHEET 2 C 2 TRP A 174 GLU A 178 -1 O MET A 176 N LYS A 169 SHEET 1 D 2 ARG A 205 HIS A 208 0 SHEET 2 D 2 ALA A 213 VAL A 216 -1 O VAL A 216 N ARG A 205 SHEET 1 E 3 ARG A 386 PRO A 388 0 SHEET 2 E 3 ARG A 438 ASN A 440 -1 O ILE A 439 N TRP A 387 SHEET 3 E 3 VAL A 431 GLU A 432 -1 N GLU A 432 O ARG A 438 SHEET 1 F 6 LEU A 640 LEU A 645 0 SHEET 2 F 6 ARG A 601 GLY A 606 1 N VAL A 603 O ARG A 641 SHEET 3 F 6 LEU A 562 VAL A 567 1 N ASP A 564 O MET A 604 SHEET 4 F 6 LEU A 662 GLN A 665 1 O LEU A 662 N PHE A 563 SHEET 5 F 6 LEU A 687 GLY A 690 1 O ILE A 689 N SER A 663 SHEET 6 F 6 PHE A 709 ILE A 710 1 O PHE A 709 N THR A 688
LINK NZ LYS A 680 C4A PLP A 999 1555 1555 1.35
SITE 1 AC1 17 GLY A 134 TRP A 491 LYS A 568 LYS A 574 SITE 2 AC1 17 TYR A 648 ARG A 649 VAL A 650 GLY A 675 SITE 3 AC1 17 THR A 676 GLY A 677 LYS A 680 HOH A1062 SITE 4 AC1 17 HOH A1070 HOH A1114 HOH A1115 HOH A1121 SITE 5 AC1 17 HOH A1306 SITE 1 AC2 15 ASN A 284 ASP A 339 HIS A 341 HIS A 377 SITE 2 AC2 15 ASN A 484 TYR A 573 GLU A 672 ALA A 673 SITE 3 AC2 15 SER A 674 GLY A 675 HOH A1098 HOH A1217 SITE 4 AC2 15 HOH A1306 HOH A1309 HOH A1330
CRYST1 128.626 128.626 116.163 90.00 90.00 90.00 P 43 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.007774 0.000000 0.000000 0.00000
SCALE2 0.000000 0.007774 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008609 0.00000